In samples of patients from Group 1, the immunohistochemical assessment of protein Ki-67 revealed scarce immunoreactive tumor cells (20% ± 3,2) (Figure 5), while in samples of patients from Group 2, cells with positivity were more abundant (47% ± 6,3). Here, MKI67 is linked to neoplasm.